论文信息 - A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab - 字舞流文

A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab

M. Kaminski | M. Czuczman | J. Friedberg | L. Rimsza | R. Fisher | B. Cheson | T. Miller | M. Leblanc | R. Braziel | D. Maloney | J. Unger | S. Dakhil | O. Press | A. Gopal | C. Spier | M. LeBlanc